Dupilumab Improves Quality of Life and Work Productivity in Patients With Atopic Hand and Foot Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
J Am Acad Dermatol 2024 Jun 01;90(6)1190-1199, EL Simpson, JI Silverberg, M Worm, G Honari, K Masuda, E Syguła, MLA Schuttelaar, E Mortensen, E Laws, B Akinlade, N Patel, J Maloney, H Paleczny, D Delevry, J Xiao, A Dubost-Brama, A BansalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.